The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiac Marker Analyzer Market Research Report 2025
Synopsis
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Cardiac Marker Analyzer (Cardiac Reader Systems) offers a high point of care testing results for the diagnosis of cardiac-related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays.
The global Cardiac Marker Analyzer market was valued at US$ 240.4 million in 2023 and is anticipated to reach US$ 351.5 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Abbott Laboratories is the world's largest manufacturers of the Cardiac Marker Analyzer with a market share of about 24%. Other major manufacturers include Roche, Quidel and Danaher etc. The America region is the world's largest market for Cardiac Marker Analyzer, has a share about 44%, followed by Asia-Pacific and Europe, with share 34% and 19%, separately. In terms of product types, portable is the largest market segment, occupying for a share of about 78%. In terms of product applications, Cardiac Marker Analyzer is mainly used in hospitals, with a market share of 60%, followed by clinics.
This report aims to provide a comprehensive presentation of the global market for Cardiac Marker Analyzer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Marker Analyzer.
Report Scope
The Cardiac Marker Analyzer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Marker Analyzer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Marker Analyzer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quidel
Abbott Laboratories
Roche
Danaher
Siemens Healthineers
LSI Medience
CardioGenics
Trinity Biotech
Boditech
Lifesign
Response Biomedical
Other
Segment by Type
Desktop
Portable
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiac Marker Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiac Marker Analyzer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Cardiac Marker Analyzer (Cardiac Reader Systems) offers a high point of care testing results for the diagnosis of cardiac-related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays.
The global Cardiac Marker Analyzer market was valued at US$ 240.4 million in 2023 and is anticipated to reach US$ 351.5 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Abbott Laboratories is the world's largest manufacturers of the Cardiac Marker Analyzer with a market share of about 24%. Other major manufacturers include Roche, Quidel and Danaher etc. The America region is the world's largest market for Cardiac Marker Analyzer, has a share about 44%, followed by Asia-Pacific and Europe, with share 34% and 19%, separately. In terms of product types, portable is the largest market segment, occupying for a share of about 78%. In terms of product applications, Cardiac Marker Analyzer is mainly used in hospitals, with a market share of 60%, followed by clinics.
This report aims to provide a comprehensive presentation of the global market for Cardiac Marker Analyzer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Marker Analyzer.
Report Scope
The Cardiac Marker Analyzer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Marker Analyzer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Marker Analyzer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quidel
Abbott Laboratories
Roche
Danaher
Siemens Healthineers
LSI Medience
CardioGenics
Trinity Biotech
Boditech
Lifesign
Response Biomedical
Other
Segment by Type
Desktop
Portable
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiac Marker Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiac Marker Analyzer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cardiac Marker Analyzer Market Overview
1.1 Product Overview and Scope of Cardiac Marker Analyzer
1.2 Cardiac Marker Analyzer Segment by Type
1.2.1 Global Cardiac Marker Analyzer Market Value Comparison by Type (2024-2030)
1.2.2 Desktop
1.2.3 Portable
1.3 Cardiac Marker Analyzer Segment by Application
1.3.1 Global Cardiac Marker Analyzer Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Cardiac Marker Analyzer Market Size Estimates and Forecasts
1.4.1 Global Cardiac Marker Analyzer Revenue 2019-2030
1.4.2 Global Cardiac Marker Analyzer Sales 2019-2030
1.4.3 Global Cardiac Marker Analyzer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cardiac Marker Analyzer Market Competition by Manufacturers
2.1 Global Cardiac Marker Analyzer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cardiac Marker Analyzer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cardiac Marker Analyzer Average Price by Manufacturers (2019-2024)
2.4 Global Cardiac Marker Analyzer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiac Marker Analyzer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiac Marker Analyzer, Product Type & Application
2.7 Cardiac Marker Analyzer Market Competitive Situation and Trends
2.7.1 Cardiac Marker Analyzer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiac Marker Analyzer Players Market Share by Revenue
2.7.3 Global Cardiac Marker Analyzer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiac Marker Analyzer Retrospective Market Scenario by Region
3.1 Global Cardiac Marker Analyzer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cardiac Marker Analyzer Global Cardiac Marker Analyzer Sales by Region: 2019-2030
3.2.1 Global Cardiac Marker Analyzer Sales by Region: 2019-2024
3.2.2 Global Cardiac Marker Analyzer Sales by Region: 2025-2030
3.3 Global Cardiac Marker Analyzer Global Cardiac Marker Analyzer Revenue by Region: 2019-2030
3.3.1 Global Cardiac Marker Analyzer Revenue by Region: 2019-2024
3.3.2 Global Cardiac Marker Analyzer Revenue by Region: 2025-2030
3.4 North America Cardiac Marker Analyzer Market Facts & Figures by Country
3.4.1 North America Cardiac Marker Analyzer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cardiac Marker Analyzer Sales by Country (2019-2030)
3.4.3 North America Cardiac Marker Analyzer Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiac Marker Analyzer Market Facts & Figures by Country
3.5.1 Europe Cardiac Marker Analyzer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cardiac Marker Analyzer Sales by Country (2019-2030)
3.5.3 Europe Cardiac Marker Analyzer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac Marker Analyzer Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiac Marker Analyzer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cardiac Marker Analyzer Sales by Country (2019-2030)
3.6.3 Asia Pacific Cardiac Marker Analyzer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardiac Marker Analyzer Market Facts & Figures by Country
3.7.1 Latin America Cardiac Marker Analyzer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cardiac Marker Analyzer Sales by Country (2019-2030)
3.7.3 Latin America Cardiac Marker Analyzer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiac Marker Analyzer Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac Marker Analyzer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cardiac Marker Analyzer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cardiac Marker Analyzer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiac Marker Analyzer Sales by Type (2019-2030)
4.1.1 Global Cardiac Marker Analyzer Sales by Type (2019-2024)
4.1.2 Global Cardiac Marker Analyzer Sales by Type (2025-2030)
4.1.3 Global Cardiac Marker Analyzer Sales Market Share by Type (2019-2030)
4.2 Global Cardiac Marker Analyzer Revenue by Type (2019-2030)
4.2.1 Global Cardiac Marker Analyzer Revenue by Type (2019-2024)
4.2.2 Global Cardiac Marker Analyzer Revenue by Type (2025-2030)
4.2.3 Global Cardiac Marker Analyzer Revenue Market Share by Type (2019-2030)
4.3 Global Cardiac Marker Analyzer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cardiac Marker Analyzer Sales by Application (2019-2030)
5.1.1 Global Cardiac Marker Analyzer Sales by Application (2019-2024)
5.1.2 Global Cardiac Marker Analyzer Sales by Application (2025-2030)
5.1.3 Global Cardiac Marker Analyzer Sales Market Share by Application (2019-2030)
5.2 Global Cardiac Marker Analyzer Revenue by Application (2019-2030)
5.2.1 Global Cardiac Marker Analyzer Revenue by Application (2019-2024)
5.2.2 Global Cardiac Marker Analyzer Revenue by Application (2025-2030)
5.2.3 Global Cardiac Marker Analyzer Revenue Market Share by Application (2019-2030)
5.3 Global Cardiac Marker Analyzer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Quidel
6.1.1 Quidel Corporation Information
6.1.2 Quidel Description and Business Overview
6.1.3 Quidel Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Quidel Cardiac Marker Analyzer Product Portfolio
6.1.5 Quidel Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Cardiac Marker Analyzer Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Cardiac Marker Analyzer Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Danaher
6.4.1 Danaher Corporation Information
6.4.2 Danaher Description and Business Overview
6.4.3 Danaher Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Danaher Cardiac Marker Analyzer Product Portfolio
6.4.5 Danaher Recent Developments/Updates
6.5 Siemens Healthineers
6.5.1 Siemens Healthineers Corporation Information
6.5.2 Siemens Healthineers Description and Business Overview
6.5.3 Siemens Healthineers Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Siemens Healthineers Cardiac Marker Analyzer Product Portfolio
6.5.5 Siemens Healthineers Recent Developments/Updates
6.6 LSI Medience
6.6.1 LSI Medience Corporation Information
6.6.2 LSI Medience Description and Business Overview
6.6.3 LSI Medience Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LSI Medience Cardiac Marker Analyzer Product Portfolio
6.6.5 LSI Medience Recent Developments/Updates
6.7 CardioGenics
6.6.1 CardioGenics Corporation Information
6.6.2 CardioGenics Description and Business Overview
6.6.3 CardioGenics Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CardioGenics Cardiac Marker Analyzer Product Portfolio
6.7.5 CardioGenics Recent Developments/Updates
6.8 Trinity Biotech
6.8.1 Trinity Biotech Corporation Information
6.8.2 Trinity Biotech Description and Business Overview
6.8.3 Trinity Biotech Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Trinity Biotech Cardiac Marker Analyzer Product Portfolio
6.8.5 Trinity Biotech Recent Developments/Updates
6.9 Boditech
6.9.1 Boditech Corporation Information
6.9.2 Boditech Description and Business Overview
6.9.3 Boditech Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boditech Cardiac Marker Analyzer Product Portfolio
6.9.5 Boditech Recent Developments/Updates
6.10 Lifesign
6.10.1 Lifesign Corporation Information
6.10.2 Lifesign Description and Business Overview
6.10.3 Lifesign Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lifesign Cardiac Marker Analyzer Product Portfolio
6.10.5 Lifesign Recent Developments/Updates
6.11 Response Biomedical
6.11.1 Response Biomedical Corporation Information
6.11.2 Response Biomedical Cardiac Marker Analyzer Description and Business Overview
6.11.3 Response Biomedical Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Response Biomedical Cardiac Marker Analyzer Product Portfolio
6.11.5 Response Biomedical Recent Developments/Updates
6.12 Other
6.12.1 Other Corporation Information
6.12.2 Other Cardiac Marker Analyzer Description and Business Overview
6.12.3 Other Cardiac Marker Analyzer Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Other Cardiac Marker Analyzer Product Portfolio
6.12.5 Other Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac Marker Analyzer Industry Chain Analysis
7.2 Cardiac Marker Analyzer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac Marker Analyzer Production Mode & Process
7.4 Cardiac Marker Analyzer Sales and Marketing
7.4.1 Cardiac Marker Analyzer Sales Channels
7.4.2 Cardiac Marker Analyzer Distributors
7.5 Cardiac Marker Analyzer Customers
8 Cardiac Marker Analyzer Market Dynamics
8.1 Cardiac Marker Analyzer Industry Trends
8.2 Cardiac Marker Analyzer Market Drivers
8.3 Cardiac Marker Analyzer Market Challenges
8.4 Cardiac Marker Analyzer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
